Rabbit Recombinant Monoclonal INSL3 antibody. Suitable for IP, WB and reacts with Human, Mouse samples. Cited in 2 publications.
View Alternative Names
RLF, RLNL, INSL3, Insulin-like 3, Leydig insulin-like peptide, Relaxin-like factor, Ley-I-L
- IP
Supplier Data
Immunoprecipitation - Anti-INSL3 antibody [EPR14834(2)] (AB199536)
INSL3 was immunoprecipitated from 1mg of Human testis whole cell lysate with ab199536 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab199536 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : Human testis whole cell lysate 10 μg (Input). Lane 2 : ab199536 IP in Human testis whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab199536 in Human testis whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-INSL3 antibody [EPR14834(2)] (ab199536)
Predicted band size: 14 kDa
false
- WB
Supplier Data
Western blot - Anti-INSL3 antibody [EPR14834(2)] (AB199536)
INSL3 is expressed in prenatal and postnatal Leydig cells. Human fetal heart, kidney, spleen, NCCIT, A431 & Jurkat cells represent negative controls in this experiment.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-INSL3 antibody [EPR14834(2)] (ab199536) at 1/5000 dilution
Lane 1:
Mouse testis lysate at 10 µg
Lane 2:
Human testis lysate at 10 µg
Lane 3:
Human fetal heart lysate at 10 µg
Lane 4:
Human fetal kidney lysate at 10 µg
Lane 5:
Human fetal spleen lysate at 10 µg
Lane 6:
NCCIT (Human pluripotent embryonal carcinoma) whole cell lysate at 10 µg
Lane 7:
A431 (Human epidermoid carcinoma) whole cell lysate at 10 µg
Lane 8:
Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 14 kDa
Observed band size: 15 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-INSL3 antibody [EPR14834(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Insulin-like peptide 3 influences the development of male gonads and the descent of testes during embryonic development making it important for reproductive success. INSL3 also functions in ovarian follicle maturation in females. This hormone operates by binding to the RXFP2 receptor forming a complex that triggers signaling cascades leading to tissue development and differentiation. However the extent of its involvement in female reproductive processes remains under investigation.
Pathways
Insulin-like peptide 3 functions mainly through the cAMP signaling pathway via its interaction with RXFP2 which plays an important role in regulating cell proliferation and differentiation. INSL3 influences the reproductive hormone axis working alongside other hormones like testosterone and luteinizing hormone to coordinate testicular descent and manage reproductive function. Its signaling pathway impacts various stages of gonadal development and maturation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Birth defects research 117:e2485 PubMed40386949
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 299:102880 PubMed36626984
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com